Table 7a.
Criteria | Diagnosis |
---|---|
Family history of Marfan syndrome absent | |
AO (Z-score >2) and ectopia lentisa | Marfan syndrome |
AO (Z-score >2) and FBN1 gene mutation | Marfan syndrome |
AO (Z-score >2) and systemic scoreb >7a | Marfan syndrome |
Ectopia lentis and FBN1 gene mutation with known AOc | Marfan syndrome |
Ectopia lentis with or without systemic score >7b and FBN1 gene mutation Unknown with AOd or no FBN1 gene mutation | Ectopia lentis syndrome |
AO (Z-score <2) and systemic scoreb >5, with at least one skeletal feature, without ectopia lentis | MASS |
Mitral valve prolapse, AO (Z-score <2), and systemic scoreb <5, without ectopia lentis | Mitral valve prolapse syndrome |
Family history of Marfan syndrome present | |
Ectopia lentis | Marfan syndrome |
Systemic score>7a | Marfan syndrome |
AO (Z-score >2) in patients aged >20 years, (Z-score >3) in patients aged <20 yearsa | Marfan syndrome |
aWithout discriminating features of Shprintzen–Goldberg syndrome, Loeys–Dietz syndrome, or vascular form of Ehlers–Danlos syndrome and after collagen biochemistry and TGFBR1 and 2 and COL3A1 gene testing, if indicated. bAs described in Table 7b. cFBN1 gene mutation that has been identified in a patient with aortic aneurysm. dFBN1 gene mutation that has not been associated with aortic root aneurysm/dissection. AO=aortic diameter at the sinuses of Valsalva with indicated Z-score or aortic root dissection; FBN1=fibrillin-1 gene; MASS=mitral valve prolapse, aorta root diameter at the upper limit of normal, striae, and skeletal features similar to Marfan syndrome